Isocryptomerin, a novel membrane-active antifungal compound from Selaginella tamariscina

Biochemical and Biophysical Research Communications

Volumn 379, Issue 3, 2009, Pages 676-680

  Lee, Juneyoung ^a   Choi, Yunjung ^a   Woo, Eun Rhan ^b   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Antifungal activity; Biflavonoid; Isocryptomerin; Membrane disruption mechanism(s)

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; ANTIFUNGAL AGENT; ISOCRYPTOMERIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL FUNCTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENERGY METABOLISM; FUNGAL STRAIN; HEMOLYSIS; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; SELAGINELLA; SELAGINELLA TAMARISCINA;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL MEMBRANE; DIPHENYLHEXATRIENE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLAVONES; FLUORESCENT DYES; HEMOLYSIS; HUMANS; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; SELAGINELLACEAE;

CANDIDA ALBICANS; SELAGINELLA TAMARISCINA;

EID: 58549098767     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.030     Document Type: Article

References (35)

1. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Aspects Med. 27 (2006) 1-93
2. Lin R.C., Skaltsounis A.L., Seguin E., Tillequin F., and Koch M. Phenolic constituents of Selaginella doederleinii. Planta Med. 60 (1994) 168-170
3. Darias V., Bravo L., Rabanal R., Sánchez Mateo C., González Luis R.M., and Hernández Pérez A.M. New contribution to the ethnopharmacological study of the Canary Islands. J. Ethnopharmacol. 25 (1989) 77-92
4. Lin C.C., and Kan W.S. Medicinal plants used for the treatment of hepatitis in Taiwan. Am. J. Chin. Med. 18 (1990) 35-43
5. MacFoy C.A., and Sama A.M. Medicinal plants in Pujehun district of Sierra Leone. J. Ethnopharmacol. 8 (1983) 215-223
6. Winkelman M. Frequently used medicinal plants in Baja California Norte. J. Ethnopharmacol. 18 (1986) 109-131
7. Banerjee T., Valacchi G., Ziboh V.A., and van der Vliet A. Inhibition of TNFalpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-kappaB activation in A549 cells. Mol. Cell. Biochem. 238 (2002) 105-110
8. Suh S.J., Chung T.W., Son M.J., Kim S.H., Moon T.C., Son K.H., Kim H.P., Chang H.W., and Kim C.H. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch. Biochem. Biophys. 447 (2006) 136-146
9. Gil B., Sanz M.J., Terencio M.C., Gunasegaran R., Paya M., and Alcaraz M.J. Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity. Biochem. Pharmacol. 53 (1997) 733-740
10. Lim H., Son K.H., Chang H.W., Kang S.S., and Kim H.P. Effects of anti-inflammatory biflavonoid, ginkgetin, on chronic skin inflammation. Biol. Pharm. Bull. 29 (2006) 1046-1049
11. Amella M., Bronner C., Briancon F., Haag M., Anton R., and Landry Y. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1 (1985) 16-20
12. Bronner C., and Landry Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 16 (1985) 147-151
13. Ito C., Itogawa M., Miyamoto Y., Rao K.S., Okuda J., Takayasu Y., Mukainaka T., Tokuda H., Nishino H., and Furukawa H. A new biflavonoid from Calophyllum panciflorum with antitumor-promoting activity. J. Nat. Prod. 62 (1999) 1668-1671
14. Shinozaki Y., Fukamiya N., Uchiyama C., Okano M., Tagahara K., Bastow K.F., and Lee K.H. Multidrug resistant cancer cells susceptibility to cytotoxic taxane diterpenes from Taxus yunnanensis and Taxus chinensis. Bioorg. Med. Chem. Lett. 12 (2002) 2785-2788
15. Chen J., Chang H.W., Kim H.P., and Park H. Synthesis of phospholipase A2 inhibitory biflavonoids. Bioorg. Med. Chem. Lett. 16 (2006) 2373-2375
16. Lee C.W., Choi H.J., Kim H.S., Kim D.H., Chang I.S., Moon H.T., Lee S.Y., Oh W.K., and Woo E.R. Biflavonoids isolated from Selaginella tamariscina regulate the expression of matrix metalloproteinase in human skin fibroblasts. Bioorg. Med. Chem. 16 (2008) 732-738
17. Kim H.P., Park H., Son K.H., Chang H.W., and Kang S.S. Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action. Arch. Pharmacol. Res. 31 (2007) 265-273
18. Lee S.J., Choi J.H., Son K.H., Chang H.W., Kang S.S., and Kim H.P. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci. 57 (1995) 551-558
19. Silva G.L., Chai H., Gupta M.P., Farnsworth N.R., Cordell G.A., Pezzuto J.M., Beecher C.W., and Kinghorn A.D. Cytotoxic biflavonoids from Selaginella willdenowii. Phytochemistry 40 (1995) 129-134
20. Jahn B., Martin E., Stueben A., and Bhakdi S. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microbiol. 33 (1995) 661-667
21. Sung W.S., Lee J., and Lee D.G. Fungicidal effect and the mode of action of piscidin 2 derived from hybrid striped bass. Biochem. Biophys. Res. Commun. 371 (2008) 551-555
22. Klepser M.E., Ernst E.J., Lewis R.E., Ernst M.E., and Pfaller M.A. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42 (1998) 1207-1212
23. Sengupta S., Jana M.L., Sengupta D., and Naskar A.K. A note on the estimation of microbial glycosidase activities by dinitrosalicylic acid reagent. Appl. Microbiol. Biotechnol. 53 (2000) 732-735
24. Ghoul M., Pommepuy M., Moillo-Batt A., and Cormier M. Effect of carbonyl cyanide m-chlorophenylhydrazone on Escherichia coli halotolerance. Appl. Environ. Microbiol. 55 (1989) 1040-1043
25. Liao R.S., Rennie R.P., and Talbot J.A. Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob. Agents Chemother. 43 (1999) 1034-1041
26. Lee D.G., Kim H.N., Park Y., Kim H.K., Choi B.H., Choi C.H., and Hahm K.S. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim. Biophys. Acta 1598 (2002) 185-194
27. Lee D.G., Park Y., Kim P.I., Jeong H.G., Woo E.R., and Hahm K.S. Influence on the plasma membrane of Candida albicans by HP (2-9)-magainin 2 (1-12) hybrid peptide. Biochem. Biophys. Res. Commun. 297 (2002) 885-889
28. 27 from Streptococcus pneumoniae. Biochem. Biophys. Res. Commun. 363 (2007) 806-810
29. Hartsel S., and Bolard J. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17 (1996) 445-449
30. Veerman E.C., Valentijn-Benz M., Nazmi K., Ruissen A.L., Walgreen-Weterings E., Van Marle J., Doust A.B., Van't Hof W., Bolscher J.G., and Amerongen A.V. Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J. Biol. Chem. 282 (2007) 18831-18841
31. Wilson D.F., and Chance B. Azide inhibition of mitochondrial electron transport. I. The aerobic steady state of succinate oxidation. Biochim. Biophys. Acta 131 (1967) 421-430
32. Hoffman H.L., Ernst E.J., and Klepser M.E. Novel triazole antifungal agents. Expert Opin. Inv. Drug. 9 (2000) 593-605
33. Sung W.S., and Lee D.G. In vitro candidacidal action of Korean red ginseng saponins against Candida albicans. Biol. Pharm. Bull. 31 (2008) 139-142
34. Wade D., Andreu D., Mitchell S.A., Silveria A.M., Boman A., Boman H.G., and Merrifield R.B. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int. J. Pept. Protein Res. 40 (1992) 429-436
35. Maher S., and McClean S. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71 (2006) 1289-1298